Logo
Logo


ISSN: 0300-9041
ISSNe: 2594-2034


Indizada en: SciELO, Índice Médico Latinoamericano, LILACS, Medline
Editada por la Federación Mexicana de Colegios de Obstetricia, y Ginecologia AC
Fundada por la Asociación Mexicana de Ginecología y Obstetricia en 1945
 

INFORMACIÓN EXCLUSIVA PARA LOS PROFESIONALES DE LA SALUD


Periodicidad: continua
Abreviatura: Ginecol Obstet Mex
ISSN: 0300-9041
ISSNe: 2594-2034
Indizada en: Scimago, Índice Médico Latinoamericano, Lilacs, Medline, Science Citation Index, Ulrich, Ebsco.

Tratamiento inmediato en pacientes con cribado combinado (citología y prueba de VPH) para cáncer de cuello uterino. Revisión narrativa

Immediate treatment in patients with screening combined (cytology and HPV test) for cancer of cervix. A narrative review.

Ginecol Obstet Mex. 2019 octubre;87(10):696-705.

https://doi.org/10.24245/gom.v87i10.3063

Mario Arturo González-Mariño

Departamento de Obstetricia y Ginecología, Facultad de Medicina, Universidad Nacional de Colombia, Bogotá, Colombia.


Corrrespondencia:

Mario Arturo González Mariño
marioar90@hotmail.com

Debe citarse como:

González-Mariño MA. Tratamiento inmediato en pacientes con cribado combinado (citología y prueba de VPH) para cáncer de cuello uterino. Revisión narrativa. 2019 octubre;87(10):696-705. https://doi.org/10.24245/gom.v87i10.3063

Resumen

ANTECEDENTES: Muchos países han optado por pruebas de ADN del virus del papiloma humano y citología, como prueba de triage para evaluación diagnóstica y establecer el tratamiento de acuerdo con los resultados. La colposcopia orienta la toma de biopsias.

OBJETIVO: Determinar porqué la escisión electroquirúrgica inmediata debe elegirse, en casos con lesión escamosa intraepitelial de alto grado, en programas de detección de VPH de alto riesgo y a la citología como prueba de triage.

METODOLOGÍA: Búsqueda en MEDLINE y Embase con los términos y filtros: uterine cervical neoplasms and mass Screening and papillomaviridae (ensayos clínicos controlados), colposcopy (ensayos clínicos controlados), uterine cervical neoplasms mass screening and papillomaviridae or papillomaviridae (metanálisis), squamous intraepithelial lesions of the cervix and therapeutics (metanálisis y revisiones sistemáticas), see and treat, screen-and-treat and cervix. Y en EBM Reviews - Cochrane Database of Systematic Reviews con colposcopy, cervical intraepithelial neoplasia, uterine cervical neoplasms and mass screening and papillomaviridae. La búsqueda se realizó entre diciembre de 2018 y marzo de 2019, limitándose a artículos publicados entre enero de 2000 y diciembre 2018, efectuándose una revisión narrativa con búsqueda manual.

RESULTADOS: De 1699 artículos localizados se seleccionaron 73 para su análisis; sin embargo, en ninguno se encontró una relación total con el objetivo. Los artículos seleccionados sirvieron de base para analizar el rendimiento de las pruebas de cribado y el conocimiento actual de la escisión electroquirúrgica inmediata.

CONCLUSIONES: En programas con detección de VPH de alto riesgo y citología como prueba de triage se recomienda la escisión electroquirúrgica inmediata cuando haya una lesión escamosa intraepitelial de alto grado.

PALABRAS CLAVE: ADN; virus del papiloma humano; citología; triage; colposcopia; lesiones intraepiteliales escamosas del cuello uterino; neoplasias uterinas cervicales.

Abstract

BACKGROUND: Many countries have opted for DNA testing of human papilloma virus and cytology as a triage test for diagnostic evaluation. Colposcopy is used to guide the taking of biopsies.

OBJECTIVE: To demonstrate the reasons why immediate electro-surgical excision should be chosen in cases with high-grade squamous intraepithelial lesion in programs with detection of high-risk human papillomavirus and cytology as a triage test.

METHODOLOGY: Search in MEDLINE, Embase with uterine cervical neoplasms and mass Screening and papillomaviridae (randomized controlled trial), colposcopy (randomized controlled trial), uterine cervical neoplasms mass screening and papillomaviridae or papillomaviridae (meta-Analysis), squamous intraepithelial lesions of the cervix and therapeutics , (meta-analysis and systematic reviews), squamous intraepithelial lesions of the cervix and see and treat, screen-and-treat and cervix and EBM Reviews - Cochrane Database of Systematic Reviews with colposcopy, cervical intraepithelial neoplasia, uterine cervical neoplasms and mass screening and papillomaviridae. Searches were from December 2018 to March 2019. Finally, it was changed to a narrative review and manual search.

RESULTS: Out of 1699 articles located, 73 were selected for reading the entire article, none of which was found related to the objective. However, these articles served as the basis for analysing the performance of screening tests and the current knowledge about immediate electro-surgical excision.

CONCLUSIONS: It is recommended immediate electro-surgical excision in cases with high-grade squamous intraepithelial lesion in programs with detection of high-risk human papillomavirus and cytology as a triage test.

KEYWORDS: DNA; Human Papilloma Virus; Cytology; triage; Colposcopy; Squamous intraepitelial lesions of the cervix; Uterine cervical Neoplasms.

    1. Bray F, et al. Global cancer statistics 2018: GLOBOCAN estimates of cancer incidence and mortality for 36 cancers in 185 countries. CA Cancer J Clin. 2018; 68: 394-424. doi: 10.3322/caac.21492
    2. Ronco G, Rossi PG. Role of HPV DNA testing in modern gynaecological practice. Best Pract Res Clin Obstet Gynaecol. 2018 Feb; 47: 107-118.. doi: 10.1016/j.bpobgyn.2017.08.002
    3. Spence AR, et al. Process of care failures in invasive cervical cancers: A systematic review and meta analysis. Prev Med. 2007; 45: 93-106. doi: 10.1016/j.ypmed.2007.06.007
    4. Ogilvie GS, et al. HPV for cervical cancer screening (HPV FOCAL): Complete Round 1 results of a randomized trial comparing HPV-based primary screening to liquid-based cytology for cervical cancer. Int J Cancer. 2017 Jan 15; 140 (2): 440-48. doi: 10.1002/ijc.30454
    5. Sellors JW. La colposcopia y el tratamiento de la neoplasia intraepitelial cervical: manual para principiantes Washington, DC: OPS, 2003;37-44. https://www.paho.org/hq/dmdocuments/2012/WHO-Colposcopymanual-2003-Spa.pdf
    6. Zaal A, et al. Agreement between colposcopic impression and histological diagnosis among human papillomavirus type 16-positive women: a clinical trial using dynamic spectral imaging colposcopy. BJOG 2012; 119: 537-44. doi: 10.1111/j.1471-0528.2012.03280.x
    7. Bekkers RL, et al. Does experience in colposcopy improve identification of high grade abnormalities? Eur J Obstet Gynecol Reprod Biol 2008; 141: 75-78. doi: 10.1016/j.ejogrb.2008.07.007
    8. Pretorius RG, et al. Colposcopically directed biopsy, random cervical biopsy, and endocervical curettage in the diagnosis of cervical intraepithelial neoplasia II or worse. Am J Obstet Gynecol 2004; 191: 430-34. doi: 10.1016/j.ajog.2004.02.065
    9. ASCUS-LSIL triage Study (ALTS) Group. A randomized trial on the management of low-grade squamous intraepithelial lesion cytology interpretations. Am J Obstet Gynecol 2003; 188: 1393-400. https://doi.org/10.1067/mob.2003.462
    10. Massad LS, Collins YC. Strength of correlations between colposcopic impression and biopsy histology. Gynecol Oncol 2003; 89: 424-38. https://doi.org/10.1016/S0090-8258(03)00082-9
    11. Kuroki LM, et al. See-and-Treat Loop Electrosurgical Excision Procedure for High-Grade Cervical Cytology: Are We Overtreating? J Low Genit Tract Dis 2016; 20: 247-51. doi: 10.1097/LGT.0000000000000230
    12. American Society for Colposcopy and Cervical Pathology (ASCCP). Los Algoritmos y Guías de Manejo de la ASCCP Actualizadas: en español. http://www.asccp.org/asccp-guidelines. (Consulta: marzo 2019).
    13. Massad LS, et al. 2012 ASCCP Consensus Guidelines Conference. 2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors. J Low Genit Tract Dis. 2013 Apr; 17 (5 Suppl 1): S1-S27. doi: 10.1097/LGT.0b013e318287d329
    14. Jeronimo J, Schiffman M. Colposcopy at a crossroads. Am J Obstet Gynecol. 2006 Aug; 195 (2): 349-53. https://doi.org/10.1016/j.ajog.2006.01.091
    15. World Health Organization. Who guidelines for screening and treatment of precancerous lesions for cervical cancer prevention,2013. [en línea]. Dirección URL https://www.who.int/reproductivehealth/publications/cancers/screening_and_treatment_of_precancerous_lesions/en/ (Consulta: enero 2019).
    16. D’Alessandro P, et al. Loop Electrosurgical Excision Procedure versus Cryotherapy in the Treatment of Cervical Intraepithelial Neoplasia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Gynecol Minim Invasive Ther. 2018 Oct-Dec; 7 (4): 145-51. doi: 10.4103/GMIT.GMIT_56_18
    17. Meirovitz M, et al. Uterine cervix conization based on Pap smear results: the “see and treat” approach. Isr Med Assoc J. 2014; 16 (5): 303-6. https://www.ncbi.nlm.nih.gov/pubmed/24979836.
    18. Szurkus DC, Harrison TA. Loop excision for high-grade squamous intraepithelial lesion on cytology: correlation with colposcopic and histologic findings. Am J Obstet Gynecol 2003; 188 (5): 1180-82. doi 10.1067/mob.2003.282
    19. Kjellberg L1, Tavelin B. ‘See and treat’ regime by LEEP conization is a safe and time saving procedure among women with cytological high-grade squamous intraepithelial lesion. Acta Obstetricia et Gynecologica. 2007; 86: 1140-1144. doi: 10.1080/00016340701505267
    20. Koliopoulos G, et al. Cytology versus HPV testing for cervical cancer screening in the general population. Cochrane Database Syst Rev. 2017 Aug 10;8: CD008587. doi: 10.1002/14651858.CD008587.pub2.
    21. Ministerio de Salud y Protección Social. Guía de Práctica Clínica para la detección y manejo de lesiones precancerosas de cuello uterino. Guía para profesionales. Colombia 2014. http://gpc.minsalud.gov.co/gpc_sites/Repositorio/Otros_conv/GPC_Cuello_Uterino/gpc_c_uterino_profesionales.aspx (Consulta: enero 2019).
    22. Khan MJ, et al. ASCCP Colposcopy Standards: Role of Colposcopy, Benefits, Potential Harms, and Terminology for Colposcopic Practice. J Low Genit Tract Dis. 2017 Oct; 21 (4): 223-29. doi: 10.1097/LGT.0000000000000338
    23. Dunn TS, et al. A “see and treat” management for high-grade squamous intraepithelial lesion PAP smears. J Low Genit Tract Dis. 2003 Apr; 7 (2): 104-6. doi: 10.1097/00128360-200304000-0000
    24. Schlichte MJ, Guidry J. Current Cervical Carcinoma Screening Guidelines. J. Clin. Med. 2015, 4, 918-932. doi: 10.3390/jcm4050918
    25. Chrysostomou AC, et al. Cervical Cancer Screening Programs in Europe: The Transition Towards HPV Vaccination and Population-Based HPV Testing. Viruses. 2018; 10 (12). pii: E729. doi: 10.3390/v10120729.
    26. Leinonen M, et al. Age-Specific Evaluation of Primary Human Papillomavirus Screening vs Conventional Cytology in a Randomized Setting. J Natl Cancer Inst 2009; 101: 1612-23. doi: 10.1093/jnci/djp367
    27. Bergeron C, et al. Informed Cytology for Triaging HPV-Positive Women: Substudy Nested in the NTCC Randomized Controlled Trial. JNCI J Natl Cancer Inst 2015; 107 (2): dju423 . doi: 10.1093/jnci/dju423
    28. Poljak M, et al. Commercially available molecular tests for human papillomaviruses (HPV): 2015 update. J Clin Virol. 2016 ;76 Suppl 1. doi: 10.1016/j.jcv.2015.10.023
    29. Arbyn M, et al. Which high-risk HPV assays fulfil criteria for use in primary cervical cancer screening. Clin. Microbiol. Infect. 2015; 21 (9): 817-26. doi: 10.1016/j.cmi.2015.04.015
    30. Iftner T, et al. Head-to-head comparison of the RNA-Based Aptima Human Papillomavirus (HPV) Assay and the DNA-Based hybrid capture 2 HPV test in a routine screening population of women aged 30–60 years in Germany. J. Clin. Microbiol 2015; 53 (8): 2509-16. doi: 10.1128/JCM.01013-15
    31. Burger EA, et al. HPV mRNA tests for the detection of cervical intraepithelial neoplasia: a systematic review. Gynecol. Oncol. 2011; 120 (3): 430-38. doi: 10.1016/j.ygyno.2010.11.013
    32. Chigbu CO, Onyebuchi AK. See-and-treat management of high-grade squamous intraepithelial lesions in a resource-constrained African setting. Int J Gynaecol Obstet. 2014 Mar; 124(3): 204-6. doi: 10.1016/j.ijgo.2013.07.040
    33. Smith HJ, et al. See-and-Treat for High-Grade Cytology: Do Young Women Have Different Rates of High-Grade Histology? J Low Genit Tract Dis. 2016; 20 (3): 243-46. doi: 10.1097/LGT.0000000000000229.
    34. Hilal Z, et al. Loop electrosurgical excision procedure with or without intraoperative colposcopy: a randomized trial. Am J Obstet Gynecol. 2018 Oct; 219 (4): 377.e1-377.e7. doi: 10.1016/j.ajog.2018.07.023
    35. Conner SN, et al. Loop electrosurgical excision procedure and risk of preterm birth: a systematic review and meta-analysis. Obstet Gynecol 2014; 123: 752-61. doi: 10.1097/AOG.0000000000000174
    36. Kyrgiou M, et al. Obstetric outcomes after conservative treatment for cervical intraepithelial lesions and early invasive disease. Cochrane Database Syst Rev. 2017 Nov 2; 11: CD012847. doi: 10.1002/14651858.CD012847.
    37. Ebisch RM, et al. Evidence supporting see-and-treat management of cervical intraepithelial neoplasia: a systematic review and meta-analysis. BJOG 2016; 123 (1): 59-66. doi: 10.1111/1471-0528.13530
    38. Sadan O, et al. Treatment of high-grade squamous intraepithelial lesions: A ‘‘see and treat’’ versus a three-step approach. Eur J Obstet Gynecol Reprod Biol. 2007; 131 (1): 73-75. doi: 10.1016/j.ejogrb.2005.12.025
    39. Demirkiran F, et al. See and treat strategy by LEEP conization in patients with abnormal cervical cytology. Ginekol Pol. 2017; 88 (7): 349-54. doi: 10.5603/GP.a2017.0066.
    40. Numnum TM, et al. A prospective evaluation of “see and treat” in women with HSIL Pap smear results: is this an appropriate strategy? J Low Genit Tract Dis. 2005; 9 (1): 2-6. doi: 10.1097/00128360-200501000-00002
    41. Aue-Aungkul A, et al. “See and treat” approach is appropriate in women with high-grade lesions on either cervical cytology or colposcopy. Asian Pac J Cancer Prev. 2011; 12 (7): 1723-26. https://www.ncbi.nlm.nih.gov/pubmed/22126552.
    42. Srisuwan S, et al. See-and-treat approach to cervical intraepithelial lesions in HRH Princess Maha Chakri Sirindhorn Medical Center. Asian Pac J Cancer Prev. 2014; 15 (8): 3483-86. doi: 10.7314/apjcp.2014.15.8.3483
    43. Monteiro AC, et al. Effectiveness of see-and-treat for approaching pre-invasive lesions of uterine cervix. Rev Saude Publica. 2009 Oct; 43 (5): 846-50. doi: 10.1590/s0034-89102009000500014
    44. Guducu N, et al. Three-step approach versus see-and-treat approach in patients with cytological abnormalities. Int J Clin Exp Med. 2013; 6 (5): 372-76. https://www.ncbi.nlm.nih.gov/pubmed/23724157.
    45. Santesso N, et al. World Health Organization Guidelines for treatment of cervical intraepithelial neoplasia 2-3 and screen-and-treat strategies to prevent cervical cancer. Int J Gynaecol Obstet. 2016 Mar; 132 (3): 252-58. doi: 10.1016/j.ijgo.2015.07.038
    46. Basu P, et al. Management algorithms for cervical cancer screening and precancer treatment for resource-limited settings. Int J Gynaecol Obstet. 2017 Jul; 138 Suppl 1: 26-32. doi: 10.1002/ijgo.12183.
    47. Nooij LS, Kagie MJ. ‘See and treat’ approach for high-grade squamous intraepithelial cervical lesions. Eur J Gynaecol Oncol. 2016; 37 (1): 22-25. https://www.ncbi.nlm.nih.gov/pubmed/27048104
    48. Petry KU. Management options for cervical intraepithelial neoplasia. Best Pract Res Clin Obstet Gynaecol. 2011 Oct; 25 (5): 641-51. doi: 10.1016/j.bpobgyn.2011.04.007
    49. Sellors JW, Sankaranarayanan R (editors). An introduction to Cervical intraepithelial neoplasia (CIN)Colposcopy and treatment of cervical intraepithelial neoplasia: a beginners’ manual. Published by The International Agency for research on Cancer, 2003: 18. https://screening.iarc.fr/doc/Colposcopymanual.pdf.
    50. Centro Cochrane Iberoamericano, traductores. Manual Cochrane de Revisiones Sistemáticas de Intervenciones, versión 5.1.0 [actualizada en marzo de 2011] [Internet]. Barcelona: Centro Cochrane Iberoamericano; 2012. http://www.cochrane.es/?q=es/node/269
    51. Wells GA, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp.
    52. Newcastle-Ottawa quality assessment scale. http://www.ohri.ca/programs/clinical_epidemiology/nosgen.pdf.
    53. The American College of Obstetrician and Gynecologists, ACOG. Practice Advisory: Cervical Cancer Screening (Update). https://www.acog.org/Clinical-Guidance-and-Publications/Practice-Advisories/Practice-Advisory-Cervical-Cancer-Screening-Update?IsMobileSet=false

Comentarios